We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ETNB

Price
9.23
Stock movement up
+0.07 (0.76%)
Company name
89bio Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.09B
Ent value
1.07B
Price/Sales
4637.96
Price/Book
2.87
Div yield
-
Div growth
-
Growth years
-
FCF payout
-0.00%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
12.84%
3 year return
43.55%
5 year return
-18.78%
10 year return
-
Last updated: 2025-05-29

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ETNB does not pay dividends or no data was received
February 27, 2025

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4637.96
Price to Book2.87
EV to Sales4590.02

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count117.58M
EPS (TTM)-2.70
FCF per share (TTM)-2.62

Income statement

Loading...
Income statement data
Revenue (TTM)234.00K
Gross profit (TTM)197.00K
Operating income (TTM)-303.86M
Net income (TTM)-288.96M
EPS (TTM)-2.70
EPS (1y forward)-2.91

Margins

Loading...
Margins data
Gross margin (TTM)84.19%
Operating margin (TTM)-129853.42%
Profit margin (TTM)-123487.18%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash91.41M
Net receivables0.00
Total current assets456.21M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment1.78M
Total assets458.30M
Accounts payable19.49M
Short/Current long term debt2.02M
Total current liabilities39.13M
Total liabilities80.19M
Shareholder's equity378.10M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-280.54M
Capital expenditures (TTM)4.00K
Free cash flow (TTM)-280.54M
Dividends paid (TTM)693.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-76.42%
Return on Assets-63.05%
Return on Invested Capital-69.73%
Cash Return on Invested Capital-67.70%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open9.42
Daily high9.64
Daily low9.07
Daily Volume1.31M
All-time high41.77
1y analyst estimate30.13
Beta0.98
EPS (TTM)-2.70
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ETNBS&P500
Current price drop from All-time high-77.90%-4.11%
Highest price drop-95.00%-56.47%
Date of highest drop9 May 20229 Mar 2009
Avg drop from high-62.83%-11.06%
Avg time to new high107 days12 days
Max time to new high1318 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ETNB (89bio Inc) company logo
Marketcap
1.09B
Marketcap category
Small-cap
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California.
Employees
70
Investor relations
-
SEC filings
CEO
Rohan Palekar
Country
USA
City
San Francisco
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...